Groupe Oncologie Radiotherapie Tete Et Cou
Clinical trials sponsored by Groupe Oncologie Radiotherapie Tete Et Cou, explained in plain language.
-
Voice-Saving cancer trial: which chemo regimen works best?
Disease control OngoingThis phase 3 trial tests two chemotherapy strategies to preserve larynx function in 256 patients with advanced larynx or hypopharynx cancer. One group gets induction chemo (TPF) followed by radiation; the other gets radiation with cisplatin. The main goal is to see which approach…
Phase: PHASE3 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated May 17, 2026 08:18 UTC
-
New combo therapy aims to extend life without sacrificing quality in advanced head and neck cancer
Disease control OngoingThis study looks at adults with head and neck cancer that has spread to a few other spots (up to 3). It compares two treatments: stereotactic radiotherapy alone versus the same radiation plus chemotherapy. The goal is to see which approach helps people live longer with a good qua…
Phase: PHASE2 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated May 11, 2026 20:50 UTC